Partial
Mostly Aligned
Patient Risk:
Low
Summary
14 of 25 claims align with the label; 11 claims are not supported by the label. Overall partial alignment.
Category Scores
Accurate Statements
Morning grogginess is a common side effect of trazodone.
6. Adverse Reactions – Somnolence/Drowsiness
Morning grogginess is especially common at higher doses used for insomnia (50-100 mg).
2. Dosage and Administration; 6. Adverse Reactions – Somnolence (dose-related)
The grogginess stems from trazodone's sedating properties.
6. Adverse Reactions – Somnolence
Patients frequently report feeling drowsy upon waking.
6. Adverse Reactions – Somnolence
Grogginess effects are more pronounced in older adults.
5. Warnings and Precautions – Geriatric Use
Grogginess is dose-dependent.
6. Adverse Reactions – Somnolence (dose-related)
Lower doses (25-50 mg) reduce risk compared to 100+ mg.
2. Dosage and Administration
Elderly patients face higher odds due to slower metabolism.
5. Warnings and Precautions – Geriatric Use
Combining with alcohol amplifies grogginess.
7. Drug Interactions – Alcohol/CNS depressants
Combining with other sedatives amplifies grogginess.
7. Drug Interactions – CNS depressants
Taking trazodone 1-2 hours before bed helps reduce morning grogginess.
2. Dosage and Administration – Take at bedtime
Start with the lowest effective dose (e.g., 25 mg).
2. Dosage and Administration
Take earlier in the evening.
2. Dosage and Administration – Take at bedtime
Avoid driving or operating machinery the next morning until clear-headed.
5. Warnings and Precautions – Impairment/Driving caution
Unsupported Statements
The sedating properties linger into the next day due to its half-life of 5-9 hours.
Not present in label
Patients frequently report feeling foggy upon waking.
Not present in label
Patients frequently report feeling sluggish upon waking.
Not present in label
Grogginess effects are more pronounced in those sensitive to antihistamine-like actions.
Not present in label
Up to 20-40% of users report next-day drowsiness in clinical studies and post-marketing data.
Not present in label
Most effects fade within 4-8 hours after waking.
Not present in label
Grogginess can persist 12+ hours in some cases.
Not present in label
Avoiding daytime naps helps reduce morning grogginess.
Not present in label
Tolerance may develop after 1-2 weeks, lessening severity for many.
Not present in label
Staying hydrated and limiting caffeine may help reduce rebound alertness issues.
Not present in label
If persistent, doctors may switch to alternatives or split doses.
Not present in label
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
Label-supported grogginess and dose-related somnolence with geriatric considerations; no contradictions identified.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Several claims about grogginess are not supported by the label; consider aligning to label wording and adding missing label-based cautions.
Suggested Improvement
Limit claims to those supported by the label; for future responses, reference exact label sections and avoid extraneous assertions. Include only label-supported dose ranges and timing cues.